Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Expansion protocol"'
Autor:
Hadas Weinstein-Marom, Gideon Gross, Michal Levi, Hadar Brayer, Jacob Schachter, Orit Itzhaki, Michal J. Besser
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Adoptive T cell therapy (ACT) holds great promise for cancer treatment. One approach, which has regained wide interest in recent years, employs antitumor T cells isolated from tumor lesions (“tumor-infiltrating lymphocytes” or TIL). It is now app
Externí odkaz:
https://doaj.org/article/5ccd7f9fc772444f87e6289aac83f7e9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Progress in Orthodontics, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Rapid maxillary expansion reduced the expander’s anchor teeth buccal alveolar bone thickness. However, the effects of alternate rapid maxillary expansions and constrictions (Alt-RAMEC) on the expander’s anchor teeth alveolar t
Externí odkaz:
https://doaj.org/article/688966222fae4187a3d5aad6b45abaf9
Autor:
Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Johan M. Van den Bergh, Zwi N. Berneman, Eva Lion, Evelien L. Smits, Viggo F. Van Tendeloo
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-13 (2016)
Abstract Background Adoptive immunotherapy is gaining momentum to fight malignancies, whereby γδ T cells have received recent attention as an alternative cell source as to natural killer cells and αβ T cells. The advent of γδ T cells is largely
Externí odkaz:
https://doaj.org/article/78513684ceb64217ab35ff0dd5af55bf
Autor:
Eric J. W. Liou, Narayan H. Gandedkar
Publikováno v:
Progress in Orthodontics, Vol 19, Iss 1, Pp 1-7 (2018)
Progress in Orthodontics
Progress in Orthodontics
Background Rapid maxillary expansion reduced the expander’s anchor teeth buccal alveolar bone thickness. However, the effects of alternate rapid maxillary expansions and constrictions (Alt-RAMEC) on the expander’s anchor teeth alveolar thickness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce2db4e7c38ebda6549a9098bb175d9
http://link.springer.com/article/10.1186/s40510-018-0237-x
http://link.springer.com/article/10.1186/s40510-018-0237-x
Autor:
Maarten A. Ligtenberg, Taisia Shmushkovich, Alexey D. Wolfson, Yuya Yoshimoto, Alexey Eliseev, Iva Truxova, Yuan Yang, Yago Pico de Coaña, Monica Betancur-Boissel, Rolf Kiessling
Publikováno v:
Molecular Therapy
Adoptive cell therapy (ACT) is becoming a prominent alternative therapeutic treatment for cancer patients relapsing on traditional therapies. In parallel, antibodies targeting immune checkpoint molecules, such as cytotoxic-T-lymphocyte-associated ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232e5fa6cc2036c1791ce7ad8c0672e2
https://doi.org/10.1016/j.ymthe.2018.04.015
https://doi.org/10.1016/j.ymthe.2018.04.015
Autor:
Ojo, Evelyn
Cancer is the second-leading cause of death in the United States and worldwide leading to 8.8 million deaths in 2015. Despite major advancements in science and health, patients at advanced stages of particular cancer types experience significant mort
Autor:
Yannick Willemen, Zwi N. Berneman, Eva Lion, Heleen H. Van Acker, Johan M.J. Van den Bergh, Viggo Van Tendeloo, Evelien Smits, Sébastien Anguille
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-13 (2016)
Journal of Hematology & Oncology
Journal of hematology and oncology
Journal of Hematology & Oncology
Journal of hematology and oncology
Background Adoptive immunotherapy is gaining momentum to fight malignancies, whereby γδ T cells have received recent attention as an alternative cell source as to natural killer cells and αβ T cells. The advent of γδ T cells is largely due to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5870a6b9e58b013260bc7e7dc7fbfae
http://link.springer.com/article/10.1186/s13045-016-0329-3
http://link.springer.com/article/10.1186/s13045-016-0329-3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jin, Chuan
Cancer immunotherapy has recently made remarkable clinical progress. Adoptive transfer of T-cells engineered with a chimeric antigen receptor (CAR) against CD19 has been successful in treatment of B-cell leukemia. Patient’s T-cells are isolated, ac
Externí odkaz:
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-300210